EFFICACY OF TIOTROPIUM IN THE TREATMENT OF COPD

  • Mindaugas Vaitkus
DOI: https://doi.org/10.37499/PIA.541
Keywords: anticholinergic, chronic obstructive pulmonary disease, inhalation therapy, tiotropium, Respimat®

Abstract

Tiotropium, a once daily inhaled anticholinergic delivered via HandiHaler®, provides bronchodilation for > 24 h and improves patient-centred outcomes. The Respimat® SoftMist Inhaler® (SMI), a novel, propellant-free inhaler, has been developed and proposed as an alternative delivery device for use with tiotropium.

How to Cite
1.
Vaitkus M. EFFICACY OF TIOTROPIUM IN THE TREATMENT OF COPD [Internet]. PIA 2011 May;8(1):55-56.[cited 2024 Nov. 22 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/541
Issue
Vol 8 No 1 (2011): Pulmonology, Immunology and Allergology
Section
Pharmacotherapy